Insider · CIK 0001817716
Myron Czuczman
Files at CTXR (Citius Pharmaceuticals, Inc.), CTOR (CITIUS ONCOLOGY, INC.). First filing -, latest -.
Myron Czuczman files SEC Form 4 as officer at CTXR (Citius Pharmaceuticals, Inc.), and also at CTOR (CITIUS ONCOLOGY, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Myron Czuczman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 19, 2025 | CTOR CITIUS ONCOLOGY, INC. | AGrant or award Common Stock | +825,000 | $0.00 | $0 | 825,000 | Dec 22, 2025 |
| Sep 19, 2025 | CTOR CITIUS ONCOLOGY, INC. | AGrant or award Common Stock | +825,000 | $0.00 | $0 | 825,000 | Dec 1, 2025 |
| Sep 19, 2025 | CTOR CITIUS ONCOLOGY, INC. | AGrant or award Common Stock | +825,000 | $0.00 | $0 | 825,000 | Sep 23, 2025 |
| Dec 12, 2024 | CTOR CITIUS ONCOLOGY, INC. | AGrant or award Stock Option (Right to Buy)derivative | +400,000 | $0.00 | $0 | 400,000 | Dec 16, 2024 |
| Nov 7, 2024 | CTXR Citius Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Purchase Common Stock)derivative | +300,000 | $0.00 | $0 | 300,000 | Nov 12, 2024 |
Questions about Myron Czuczman
Answered from the filings on this page, as of the latest one.
Is Myron Czuczman buying or selling?
Myron Czuczman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Myron Czuczman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Myron Czuczman has 0.
Where does Myron Czuczman file Form 4?
Myron Czuczman has filed Form 4 at CTXR (Citius Pharmaceuticals, Inc.) as Chief Medical Officer; CTOR (CITIUS ONCOLOGY, INC.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.